Purdue Pharma has reportedly entered into a $12 billion tentative settlement agreement to resolve thousands of opioid crisis lawsuits filed by states and cities, which will drive the company into…
Oklahoma and Purdue Pharma have reached a $270 million settlement to resolve claims the company's mislead the public about the safety of OxyContin, helping to spur the national opioid crisis.
New documents suggest Purdue Pharma aggressively pushed OxyContin prescriptions despite the risks of addiction, then called for company officials to shift the blame for the opioid crisis onto addicts and…
A conference is scheduled next week to begin preliminary settlement discussions on opioid lawsuits filed against drug manufacturers by communities and states nationwide.
A federal judge is pushing for a quick settlement for hundreds of opioid crisis lawsuits filed by communities against manufacturers nationwide, saying that a settlement should not just include money,…
Purdue Pharma is in talks with states over a potential "global settlement" that could result in billions of dollars paid out by numerous drug manufacturers to address damages caused to…
Purdue Pharma faces a lawsuit by South Carolina over claims that misleading advertising tactics contributed to the abuse of OxyContin and the nationwide opioid epidemic.
The makers of OxyContin and Risperdal have agreed to pay Kentucky $39.5 million to settle charges that they failed to warn the state's doctors and residents of the potential side…
FDA officials are worried food may interfere with the use of a new painkiller, leading to accidental overdose and misuse.
